激素替代治疗在围绝经期综合征患者中的应用

Abstract
Figure/Table
References (18)
Related Citation (15)

Download: PDF (0 KB) HTML (39 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To explore the application value of hormone replacement therapy in patients with perimenopausal syndrome.Methods A total of 80 women with perimenopausal syndrome admitted in our hospital from November 2017 to January 2019 were selected as subjects.According to the random number table method, they were divided into observation group (40 cases) and control group (40 cases).Patients in the control group were given symptomatic support treatment, orally administered with Guweisu Tablets and Kuntai Capsules.Patients in the observation group were treated with Estradiol Valerate Tablets combination with Medroxyprogesterone Acetate Dispersive Tablets.Patients in both groups were treated continuously for 6 courses of treatment, as one treatment cycle.After 1 cycle of treatment, all participants were followed up in the outpatient department for 3 months.The scores of female sexual life quality standard indicator scale (FSFI) at 3 months after intervention were compared between the two groups.Changes in levels of sex hormones, such as estradiol (E2), follicle-stimulating hormone (FSH) and luteinizing hormone (LH), at 3 months after intervention were compared between the two groups.The incidence of clinical symptoms such as irritability, fatigue, insomnia, abnormal sex life and hot flashes during the follow-up of the two groups were calculated.The changes of total cholesterol levels before and after intervention were compared between the two groups.Results Three months after intervention, FSFI scores and total score of the observation group were higher than those of the control group, with statistically significant differences (P＜0.05).Three months after intervention, the E2 level of the observation group was higher than that of the control group, and the LH and FSH levels were lower than those of the control group, with statistically significant differences (P＜0.05).During the follow-up, the incidences of clinical symptoms such as irritability, fatigue,insomnia, abnormal sex life and hot flashes in the observation group were all lower than those in the control group, with statistically significant differences (P＜0.05).At 1 and 3 months after intervention, the total cholesterol level of the two groups was lower than that before the intervention, and the total cholesterol level of the observation group was lower than that of the control group, with statistically significant differences (P＜0.05).Conclusion For perimenopausal syndrome, the combination of Estradiol Valerate Tablets with Medroxyprogesterone Acetate Dispersive Tablets can effectively improve the quality of patients' sex life, regulate the level of sex hormones, improve clinical symptoms, and reduce the level of blood lipid.

Key words： Hormone replacement Perimenopausal syndrome Clinical symptoms Blood lipid level

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	DENG Xin
	REN Ran

Cite this article:

DENG Xin,REN Ran. Application of hormone replacement therapy in patients with perimenopausal syndrome[J]. 中国当代医药, 2020, 27(11): 126-129.

URL:

http://dangdaiyiyao.com/EN/ OR http://dangdaiyiyao.com/EN/Y2020/V27/I11/126

[1]	胡贻群，何亮，李梦倪.小剂量雌激素及孕激素替代治疗围绝经期综合征的临床疗效及其安全性[J].临床合理用药杂志，2019，12（21）：36-37.
[2]	刁翯，赵立东，白文佩.雌激素对听力损失影响的研究进展[J].中国妇产科临床杂志，2019，20（4）：382-384.
[3]	陈金环.小剂量雌、孕激素替代疗法治疗围绝经期综合征的效果探讨[J].实用妇科内分泌电子杂志，2019，6（19）：59，68.
[4]	吴慧敏，王姜莹.强化激素调节方案对围绝经期综合征患者子宫内膜厚度、性激素及负面情绪状态的影响[J].中国妇幼保健，2019，34（13）：3016-3018.
[5]	张晓梅，龚海梅.激素替代治疗对MPS 患者体内的女性激素影响[J].实用妇科内分泌电子杂志，2019，6（18）：12-13.
[6]	张晨虹，林惠英，魏若菡.不同激素替代治疗对围绝经期综合征妇女的效果比较[J].中国妇幼健康研究，2019，30（6）：732-735.
[7]	尧艳俊.低剂量雌激素替代疗法对围绝经期综合征患者血清性激素水平的影响[J].临床医学，2019，39（6）：87-89.
[8]	钟冬芳.六味地黄丸联合加味逍遥丸治疗围绝经期综合征临床研究[J].新中医，2019，51（6）：79-83.
[9]	闫学花，闫利荣，陈建军，等.毫针针刺联合冥想训练对小剂量激素替代治疗围绝经期综合征绝经症状与生活质量的影响[J].河北北方学院学报（自然科学版），2019，35（4）：26-28，31.
[10]	郭霜花.甲羟孕酮与戊酸雌二醇联合治疗围绝经期综合征的临床效果观察[J].医药论坛杂志，2019，40（4）：156-157.
[11]	丁桂英，余晓.小剂量雌孕激素替代疗法治疗围绝经期综合征的疗效及激素变化探析[J].中国性科学，2019，28（4）：104-107.
[12]	张静.围绝经期妇女健康状况与保健相关进展分析[J].中国城乡企业卫生，2019，34（4）：76-78.
[13]	郭莉，王静.舒肝解郁胶囊联合氟哌噻吨美利曲辛治疗围绝经期抑郁症的临床研究[J].中国妇幼保健，2019，34（8）：1796-1799.
[14]	楼朝霞，金敏娟，梅丽娜.围绝经期和绝经后激素替代治疗对血脂的影响[J].浙江实用医学，2019，24（1）：33-34.
[15]	王海鑫.戊酸雌二醇联合甲羟孕酮对围绝经期综合征患者骨密度的影响[J].临床医学，2019，39（2）：124-125.
[16]	李娜.围绝经期女性雌激素水平与Th1/Th2 平衡及内皮功能损伤的关系[J].中国妇幼保健，2019，34（4）：848-850.
[17]	陈爱武，徐素君，陈敏，等.激素配合健康管理在围绝经期综合征中的临床应用研究[J].中国性科学，2019，28（2）：106-110.
[18]	冉宇.更年期妇女保健应用性激素替代疗法和常规保健治疗的效果对比分析[J].实用妇科内分泌杂志（电子版），2019，6（2）：17-18.